Literature DB >> 18595693

Design and optimization of aniline-substituted tetrahydroquinoline C5a receptor antagonists.

Yong Gong1, J Kent Barbay, Mieke Buntinx, Jian Li, Jean Van Wauwe, Concha Claes, Guy Van Lommen, Pamela J Hornby, Wei He.   

Abstract

A series of aniline-substituted tetrahydroquinoline C5a receptor antagonists were discovered. A functionality requirement of ortho substitution on the aniline was revealed. Secondary anilines, in general, outperformed tertiary analogs in inhibition of C5a-induced calcium mobilization. Further enhancement of activity was realized in the presence of an ortho hydroxyalkyl side chain. The functional IC(50) of selected analogs was optimized to the single-digit nanomolar level.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18595693     DOI: 10.1016/j.bmcl.2008.06.059

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Methyl 4-(4-methyl-benzamido)-2-sulfamoylbenzoate.

Authors:  Mei-Yi Wang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-11-08

2.  1-(4-Bromo-phen-yl)-2-{5-[(3,5-dimethyl-1H-pyrazol-1-yl)meth-yl]-4-phenyl-4H-1,2,4-triazol-3-ylsulfan-yl}ethanone.

Authors:  Shan-Mei Xiao
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-01-10

3.  Receptor residence time trumps drug-likeness and oral bioavailability in determining efficacy of complement C5a antagonists.

Authors:  Vernon Seow; Junxian Lim; Adam J Cotterell; Mei-Kwan Yau; Weijun Xu; Rink-Jan Lohman; W Mei Kok; Martin J Stoermer; Matthew J Sweet; Robert C Reid; Jacky Y Suen; David P Fairlie
Journal:  Sci Rep       Date:  2016-04-20       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.